Insider Trading Alert - TSO, NSP And VSCP Traded By Insiders

Yesterday, Nov. 4, 2015, 107 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $85.86 to $4,999,847.37.

Highlighted Stocks Traded by Insiders:

Tesoro (TSO) - FREE Research Report

Jackson Tracy Dawn, who is VP and Controller at Tesoro, sold 2,359 shares at $110.00 on Nov. 4, 2015. Following this transaction, the VP and Controller owned 6,145 shares meaning that the stake was reduced by 27.74% with the 2,359-share transaction.

The shares most recently traded at $115.36, up $5.36, or 4.65% since the insider transaction. Historical insider transactions for Tesoro go as follows:

  • 4-Week # shares bought: 2,000
  • 4-Week # shares sold: 914
  • 12-Week # shares bought: 2,000
  • 12-Week # shares sold: 914
  • 24-Week # shares bought: 2,000
  • 24-Week # shares sold: 17,568

The average volume for Tesoro has been 2.6 million shares per day over the past 30 days. Tesoro has a market cap of $13.5 billion and is part of the basic materials sector and energy industry. Shares are up 54.11% year-to-date as of the close of trading on Wednesday.

Tesoro Corporation, through its subsidiaries, engages in petroleum refining and marketing activities in the United States. It operates in three segments: Refining, Tesoro Logistics LP (TLLP), and Retail. The stock currently has a dividend yield of 1.78%. The company has a P/E ratio of 8.5. Currently, there are 5 analysts who rate Tesoro a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on TSO - FREE

TheStreet Quant Ratings rates Tesoro as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, notable return on equity and attractive valuation levels. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full Tesoro Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Insperity (NSP) - FREE Research Report

Mincks Jay E, who is EVP of Sales & Marketing at Insperity, sold 1,035 shares at $43.53 on Nov. 4, 2015. Following this transaction, the EVP of Sales & Marketing owned 54,926 shares meaning that the stake was reduced by 1.85% with the 1,035-share transaction.

The shares most recently traded at $43.79, up $0.26, or 0.59% since the insider transaction. Historical insider transactions for Insperity go as follows:

  • 4-Week # shares sold: 1,000
  • 12-Week # shares sold: 1,000
  • 24-Week # shares sold: 12,001

The average volume for Insperity has been 143,000 shares per day over the past 30 days. Insperity has a market cap of $1.1 billion and is part of the services sector and diversified services industry. Shares are up 29.04% year-to-date as of the close of trading on Wednesday.

Insperity, Inc. provides an array of human resources (HR) and business solutions to enhance business performance for small and medium-sized businesses in the United States. The stock currently has a dividend yield of 2.04%. The company has a P/E ratio of 27.1. Currently, there is 1 analyst who rates Insperity a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on NSP - FREE

TheStreet Quant Ratings rates Insperity as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, compelling growth in net income and solid stock price performance. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full Insperity Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

VirtualScopics (VSCP) - FREE Research Report

University Of Rochester, who is 10% Owner at VirtualScopics, sold 33,272 shares at $6.01 on Nov. 4, 2015. Following this transaction, the 10% Owner owned 189,198 shares meaning that the stake was reduced by 14.96% with the 33,272-share transaction.

The shares most recently traded at $4.16, down $1.85, or 44.38% since the insider transaction. Historical insider transactions for VirtualScopics go as follows:

  • 4-Week # shares bought: 1,400
  • 12-Week # shares bought: 1,400
  • 24-Week # shares bought: 1,400
  • 24-Week # shares sold: 88,470

The average volume for VirtualScopics has been 339,500 shares per day over the past 30 days. VirtualScopics has a market cap of $11.4 million and is part of the health care sector and health services industry. Shares are up 20.14% year-to-date as of the close of trading on Wednesday.

VirtualScopics, Inc. provides imaging solutions to the pharmaceutical, biotechnology, and medical device industries. Currently, there is 1 analyst who rates VirtualScopics a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on VSCP - FREE

TheStreet Quant Ratings rates VirtualScopics as a sell. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity, poor profit margins and generally disappointing historical performance in the stock itself. Get the full VirtualScopics Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Procter & Gamble Helps Lead Dow Jones After Upgrade From Morgan Stanley

Procter & Gamble Helps Lead Dow Jones After Upgrade From Morgan Stanley

Join Jim Cramer's Club During Our '12 Days of Holiday Deals' Sale and Save 66%!

Join Jim Cramer's Club During Our '12 Days of Holiday Deals' Sale and Save 66%!

Your Worst Enemy In a Bear Market Is Yourself

Your Worst Enemy In a Bear Market Is Yourself

Economist Perspective: Brexit Endgame in Sight?

Economist Perspective: Brexit Endgame in Sight?

Flashback Friday: Johnson & Johnson Hits Take Historic Plunge

Flashback Friday: Johnson & Johnson Hits Take Historic Plunge